Alpha Capital Management’s Core Laboratories CLB Stock Holding History

Alpha Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,359	Closed	-$1.33M	–	98
2019 Q1	$1.33M	Buy	19,359 +7,858	+68%	+$527K	0.52%	66
2018 Q4	$686K	Sell	11,501 -195	-2%	-$16.8K	0.32%	76
2018 Q3	$1.35M	Buy	11,696 +1,006	+9%	+$113K	0.54%	69
2018 Q2	$1.35M	Buy	10,690 +308	+3%	+$37.5K	0.55%	68
2018 Q1	$1.12M	Buy	10,382 +345	+3%	+$38.2K	0.48%	65
2017 Q4	$1.1M	Buy	10,037 +52	+0.5%	+$5.19K	0.52%	65
2017 Q3	$986K	Sell	9,985 -5,197	-34%	-$504K	0.47%	65
2017 Q2	$1.54M	Buy	15,182 +811	+6%	+$87.4K	0.76%	40
2017 Q1	$1.66M	Buy	14,371 +4,303	+43%	+$500K	1.16%	35
2016 Q4	$1.21M	Sell	10,068 -270	-3%	-$29.9K	0.83%	42
2016 Q3	$1.16M	Sell	10,338 -328	-3%	-$37.8K	0.84%	51
2016 Q2	$1.32M	Sell	10,666 -416	-4%	-$50.2K	0.95%	50
2016 Q1	$1.25M	Buy	+11,082	New	+$1.15M	0.9%	52

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Alpha Capital Management's CLB Position: Q2 2019 in Review

Alpha Capital Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 19,359 shares — an estimated $1.33M sold.

Alpha Capital Management first reported a position in CLB in Q1 2016 and held it in 13 quarters. The position peaked at $1.66M in Q1 2017. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Alpha Capital Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Alpha Capital Management sold 19,359 Core Laboratories shares in Q2 2019, an estimated $1.33M.
Alpha Capital Management first reported a position in Core Laboratories in Q1 2016 and held it in 13 quarters.
Alpha Capital Management's Core Laboratories position peaked at $1.66M in Q1 2017.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Alpha Capital Management's 13F filing for Q2 2019, filed 1 Aug 2019.